Conclusion
FMS, MCI
FMS
The MCI was found to be cost-effective compared with the usual clinical practice for patients with FMS. The obtained incremental costs per QALY gained for those attending the MCI did not exceed the cost-effectiveness threshold compared with the control group. Furthermore, these results were confirmed by the sensitivity analysis, showing promise for implementation. Hence, the study results support strengthening the standard practice for FMS with the proposed MCI programme in regional primary care settings. These findings provide decision-makers with evidence to reinforce the treatment strategies for FMS in the public healthcare system and its efficiency.